News

Newsletter

February 3, 2017

Amendments to TRIPs in order to ease access to medicines are now in force

After the ratifications of 2/3 of WTO (World Trade Organization) members, article 31 bis was formally brought into the text of TRIPs Agreement. Such provision aims at allowing compulsory licenses for export in order to meet the needs of countries with insufficient or no capacity of manufacturing drugs. It is a direct result of Doha Declaration on TRIPs Agreement and Public Health of 2001, which aims at striking a balance between IP protection and access to health care.
 
In line with such amendment to TRIPs, a least developed country or a country that has notified the WTO (World Trade Organization) of its lack of capacity of manufacturing a specific drug in order to meet its own needs are eligible to obtain compulsory licenses to import such drug from a third country under special conditions. Such compulsory license shall be paid and limited to the purpose of meeting the needs of the importing country. Moreover, measures shall be taken to assure that the patentee rights shall not be hampered in the exporting country. In the past, there were negotiations concerning compulsory licenses for export during the Avian flu pandemic in 2005. Some Asian countries pressured WTO to allow compulsory licenses to import generic copies of Tamiflu®. Before any license was ever implemented, countries and the manufacturer struck a deal.
 
Article 31 bis formally entered into force on January 23.
 
We shall keep you informed about the next updates of this subject. In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com.
 
Back

Last related news

March 6, 2023

Brazilian Data Protection Authority approves the Regulation on Dosimetry and Application of Administrative Penalties

The Brazilian Data Protection Authority (“ANPD” or “Authority”) published, on February 28th, 2023, the Regulation on Dosimetry and Application of Administrative Penalties Brazilian Data Protection Authority approves the Regulation on Dosimetry and Application of Administrative Penalties

Ler notícia

January 17, 2023

The Future Legal Regulation Of Artificial Intelligence In Brazil

Several Bills are being debated in the Brazilian National Congress with the objective of regulating the development and use of artificial intelligence The Future Legal Regulation Of Artificial Intelligence In Brazil

Ler notícia

January 9, 2023

New flexibility on the remittance of royalty payments abroad

In the last days of December 2022, new regulations entered into force easing up the remittance of royalty payments abroad. However, local New flexibility on the remittance of royalty payments abroad

Ler notícia